| Drug Name |
Trihexyphenidyl |
| Drug ID |
BADD_D02284 |
| Description |
Trihexyphenidyl is a centrally acting muscarinic antagonist used for treatment of parkinsonism and drug-induced extrapyramidal disorders.[L31773,L31778] Its discovery was published in 1949 in a study looking for drugs with antispasmodic activity.[A229103] Trihexyphenidyl is rarely used in the treatment of parkinsonism, and is not a first line treatment due to significant adverse effects.[L31843] It has largely been replaced by drugs such as [levodopa].[L31843]
Trihexyphenidyl was granted FDA approval on 13 May 1949.[L31768] |
| Indications and Usage |
Indicated for the treatment of parkinson's disease and extrapyramidal reactions caused by drugs. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
N04AA01 |
| DrugBank ID |
DB00376
|
| KEGG ID |
D08638
|
| MeSH ID |
D014282
|
| PubChem ID |
5572
|
| TTD Drug ID |
D09GFL
|
| NDC Product Code |
63850-6535 |
| Synonyms |
Trihexyphenidyl | Benzhexol | Artane | Cyclodol | Hipokinon | Trihexyphenidyl Hydrochloride Elixir | Parkopan | Trihexane | Trihexidyl Hydrochloride | Trihexyphenidyl Hydrochloride | Apo-Trihex | Apo Trihex | ApoTrihex | Parkinane |
